Women of reproductive age with endometriosis are not osteopenic

Fertility and Sterility

Volumn 69, Issue 5, 1998, Pages 821-825

  Ulrich, Uwe ^a   Murano, Robert ^b   Skinner, Michael A ^b   Yin, Helen ^b   Chesnut III, Charles H ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

Bone mineral density; Dual energy x ray absorptiometry; Endometriosis; Osteopenia; Osteoporosis

Indexed keywords

GOSERELIN;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DENSITOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOMETRIOSIS; FEMALE; HUMAN; LAPAROSCOPY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSTEOPENIA; OSTEOPOROSIS; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED;

EID: 0032079492     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00037-5     Document Type: Article

References (25)

1. 1. DeCherney AH, Dawood MY, Chesnut CH III. Endometriosis therapy: what impact on bone mass? Contemp Obstet Gynecol 1993;38:62-74.
2. 2. Comite F, Delman M, Hutchinson-Williams K, DeCherney AH, Jensen P. Reduced bone mass in reproductive-aged women with endometriosis. J Clin Endocrinol Metab 1989;69:837-42.
3. 3. Lane N, Baptista J, Snow-Harter C. Bone mineral density of the lumbar spine in endometriosis subjects compared to an age-similar control population. J Clin Endocrinol Metab 1991;72:510-4.
4. 4. Lane N, Baptista J, Orwoll E. Bone mineral density of the lumbar spine in women with endometriosis. Fertil Steril 1991;55:537-42.
5. 5. Dochi T, Lees B, Sidhu M, Stevenson JC. Bone density and endometriosis. Fertil Steril 1994;61:175-7.
6. 6. Rico H, Revilla M, Arnanz F, Villa LF, Perera S, Arribas I. Total and regional bone mass values and biochemical markers of bone remodelling in endometriosis. Obstet Gynecol 1993;81:272-5.
7. 7. Dmowski WP, Braun D, Gebel H. Endometriosis: genetic and immunologic aspects. Prog Clin Biol Res 1990;323:99-122.
8. 8. Gleicher N. Immune dysfunction - a potential target for treatment in endometriosis. Br J Obstet Gynaecol 1995;102(12 Suppl):4-7.
9. 9. Marshall LA, Cain DF, Dmowski WP, Chesnut CH III. Urinary N-telopeptides to monitor bone resorption while on GnRH agonist therapy. Obstet Gynecol 1996;87:350-4.
10. 10. Compston JE, Yamaguchi K, Croucher PI, Garrahan NJ, Lindsay PC, Shaw RW. The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis. Bone 1995;16:261-7.
11. 11. Taga M, Minaguchi H. Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration. Acta Obstet Gynecol Scand 1996;75:162-5.
12. 12. American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985;43:351-2.
13. 13. Genant HK, Grampp S, Glüer CS, Faulkner KG, Jergas M, Engelke K, et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 1994;9:1503-14.
14. 14. Kelly T. Bone mineral reference database for American men and women. J Bone Miner Res 1990;5(2 Suppl):S249.
15. 15. Hologic QDR 4500 Operator's Manual. Waltham, MA: Hologic Inc., 1995.
16. 16. Simms JS, Chegini N, Williams RS, Rossi AM, Dunn WA. Identification of epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in surgically induced endometriosis in rats. Obstet Gynecol 1991;78:850-7.
17. 17. Rodman GD. Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 1993;53(1 Suppl):94-8.
18. 18. Koumantakis E, Matalliotakis I, Neonaki M, Froudarakis, Georgoulias V. Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls. Arch Gynecol Obstet 1994;255:107-12.
19. 19. Soules MR, Malinak LR, Bury R, Poindexter A. Endometriosis and anovulation: a coexisting problem in the infertile female. Am J Obstet Gynecol 1976;125:412-5.
20. 20. Prior JC, Vigna YM, Schechter MT, Burgess AE. Spinal bone loss and ovulatory disturbances. N Engl J Med 1990;323:1221-7.
21. 21. Paoletti AM, Serra GG, Cagnacci A, Vacca AMB, Guerriero S, Solla E, et al. Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. Fertil Steril 1996;65:707-10.
22. 22. Wheeler JM. Epidemiology and prevalence of endometriosis. Infertil Reprod Med Clin North Am 1992;3(3):545-59.
23. 23. Ryan PJ, Spector TP, Blake GM, Doyle DV, Fogelman I. A comparison of reference bone mineral density measurements derived from two sources: referred and population based. Br J Radiol 1993;66:1138-41.
24. 24. Lehmann R, Wapniarz M, Randerath O, Kvasnicka HM, John W, Reincke M, et al. Dual-energy X-ray absorptiometry at the lumbar spine in German men and women: a cross-sectional study. Calcif Tissue Int 1995;56:350-4.
25. 25. Rencken ML, Murano R, Drinkwater BL, Chesnut CH III. In vitro comparability of dual-energy X-ray absorptiometry bone densitometers. Calcif Tissue Int 1991;48:245-8.